The Drive with Peter Attia — Tom Dayspring (5)

On: Part V of V: Lp(a), inflammation, oxLDL, remnants, and more. Episode: 24 Date: October 2018 Key Subjects: Lp(a) is a particularly high risk lipoprotein.Genetic.Important to know your Lp(a) mass or particle count.Three factors contributing to increased risk of CVD.Cholesterol,

Read More The Drive with Peter Attia — Tom Dayspring (5)

The Drive with Peter Attia — Tom Dayspring (4)

On: Part IV of V: statins, ezetimibe, PCSK9 inhibitors, niacin, cholesterol and the brain. Episode: 23 Date: October 2018 Key Subjects: Only drugs proven to reduce both cholesterol and CVD events are the ones that target increasing the clearance of

Read More The Drive with Peter Attia — Tom Dayspring (4)

The Drive with Peter Attia — Tom Dayspring (3)

On: Part III of V: HDL, reverse cholesterol transport, CETP inhibitors, and apolipoproteins. Episode: 22 Date: October 2018 Key Subjects: Old school view of cholesterol transport overly simplified:Forward cholesterol transport (FCT).Delivery of cholesterol by VLDL, LDL and chylomicrons to the

Read More The Drive with Peter Attia — Tom Dayspring (3)

The Drive with Peter Attia — Tom Dayspring (2)

On: Part II of V: Lipid metrics, lipid measurements, and cholesterol regulation. Episode: 21 Date: July 2018 Key Subjects: Lipid basics.Lipoproteins are needed to carry lipids around the bloodstream.The lipids carried primarily include triglycerides, cholesterol, phospholipids.Various types of lipoproteins.Based on

Read More The Drive with Peter Attia — Tom Dayspring (2)

The Drive with Peter Attia — Dave Feldman

On: Stress testing the lipid energy model. Episode: 19 Date: October 2018 Key Subjects: Lean Mass Hyper-Responder (LMHR):Athletic, lean, low carb (and high fat).High levels of LDL-C and LDL-P.High levels of HDL-C.Low levels of TG.Feldman Thesis:LMHR have high rate of

Read More The Drive with Peter Attia — Dave Feldman